Batch Clinical Operations Score: 3.75/5.0
Scheduled Batch & Periodic Processing | Internal audience
No-show rates average 5 to 30% depending on specialty (oncology, cardiology lowest; behavioural health, primary care highest), translating to lost revenue of $100 to $300 per missed appointment. Each no-show blocks a revenue-generating slot and creates downstream wait-list delays. Scheduling staff lack visibility into which patients are at high risk; reactive reminder calls are made 24 hours before, too late to fill a cancelled slot.
Data Sources:
Data Classification:
Data Quality Requirements:
Integration Complexity: Medium
| Criterion | Weight | Score (1-5) | Weighted |
|---|---|---|---|
| Time Recaptured | 15% | 4 | 0.60 |
| Error Reduction | 10% | 4 | 0.40 |
| Cost Avoidance | 10% | 4 | 0.40 |
| Strategic Leverage | 5% | 4 | 0.20 |
| Data Availability | 15% | 4 | 0.60 |
| Process Clarity | 15% | 3 | 0.45 |
| Ease of Implementation | 10% | 3 | 0.30 |
| Fallback Available | 10% | 4 | 0.40 |
| Audience (Int/Ext) | 10% | 4 | 0.40 |
| Composite | 100% | 3.75 |
No-show prevention is operationally high-value: a 5% reduction in no-shows reclaims $50K to $500K annually depending on appointment volume and speciality. The data is mature (appointment history, demographics), and the prediction problem is well-studied. Successful interventions are easily measured (showed up vs. no-show), allowing for rapid model iteration.
Sprint 0 (2 weeks) + 3 build sprints (6 weeks)
No-show prediction runs nightly on the appointment schedule: identify high-risk patients, initiate outreach the next morning. The initial 2-week sprint focuses on a simple logistic regression model using historical appointment and demographics data; subsequent sprints add weather/seasonal features, SMS integration, and outcomes tracking. This is a medium-complexity use case suitable for data science teams.
From zero to a governed, production agent in 6 weeks.
Sprint Factory Schedule a BriefingBefore deploying this use case, review these agentic AI risks from the Corvair Risk Catalogue. Each is scored on the DAMAGE framework and mapped to regulatory expectations.
More Healthcare use cases